Arthrex petitions Fed Circ again over ‘inferior officers’

Arthrex says that it did not get the “remedy” ordered by the US Supreme Court in its landmark case against Smith & Nephew.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

MedTech

Fed Circ refuses to rehear Insulet’s $59.4m trade secret loss

20 October 2026 A panel rejected the Omnipod maker’s request for a rehearing in its trade secrets dispute with South Korean insulin pump maker EOFlow, leaving in place a ruling that overturned a $59.4 million damages award and raising questions over the three-year statute of limitations under the DTSA.

MedTech

Align Technology notches another win in escalating clear aligner feud

19 October 2026 The US clear aligner giant has dealt another blow to a Chinese rival, securing an infringement ruling at the UPC as the pair wage a growing patent dispute across Europe, the US and China.

MedTech

Boston Scientific expands dispute with J&J unit over cardiac-access technology

12 October 2026 The two major medical device makers are clashing over Atraverse’s Hotwire system, with Boston Scientific claiming the product infringes its patented radiofrequency transseptal-access technology, used in heart surgery.

More features

Fed Circ refuses to rehear Insulet’s $59.4m trade secret loss

Boehringer accuses Dr Reddy’s of ‘weaponising’ plausibility

Align Technology notches another win in escalating clear aligner feud

Guardant loses second patent challenge to TwinStrand amid $245m damages fallout

Boehringer and Dr Reddy’s spar over plausibility as trial wraps up

Haynes Boone expands in California with new office

Accord’s generic hopes dashed in cyanide antidote ruling

Novo’s semaglutide protection weakens after European ruling

Arthrex petitions Fed Circ again over ‘inferior officers’

More on this story

Editor's picks

Editor's picks

More features